EGFR-targeted therapies in lung cancer: predictors of response and toxicity

Author： Heist Rebecca Suk   Christiani David  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.10, Iss.1, 2009-01, pp. : 59-68

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Pharmacogenomics of lung cancer: with a view to address EGFR-targeted therapies

By Joshi Victoria A   Kucherlapati Raju  

Pharmacogenomics, Vol. 8, Iss. 9, 2007-09 ,pp. : 1211-1220

Future Medicine

Access to resources Recommend Favorite

Targeted Therapies in Lung Cancer

By  

Current Pharmaceutical Design, Vol. 15, Iss. 2, 2009-01 ,pp. : 188-206

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted therapies in small-cell lung cancer

By Fernainy Khaled   Saba Nabil  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 8, 2007-08 ,pp. : 1033-1041

Informa Healthcare

Access to resources Recommend Favorite

Targeted Therapies for Non-Small Cell Lung Cancer

By  

Current Pharmaceutical Design, Vol. 13, Iss. 27, 2007-09 ,pp. : 2810-2831

Bentham Science Publishers

Access to resources Recommend Favorite

Molecularly-targeted therapies for non-small cell lung cancer

By Ramalingam Suresh   Belani Chandra P  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 15, 2005-12 ,pp. : 2667-2679

Informa Healthcare

Access to resources Recommend Favorite